1,124 results on '"Bièche, Ivan"'
Search Results
2. Tumor mutational burden assessment and standardized bioinformatics approach using custom NGS panels in clinical routine
3. CYYR1 promotes the degradation of the E3 ubiquitin ligase WWP1 and is associated with favorable prognosis in breast cancer
4. WWOX binds MERIT40 and modulates its function in homologous recombination, implications in breast cancer
5. Randomized phase II study of preoperative afatinib in untreated head and neck cancers: predictive and pharmacodynamic biomarkers of activity
6. Oxidative phosphorylation is a metabolic vulnerability of endocrine therapy and palbociclib resistant metastatic breast cancers
7. Homologous recombination deficiency derived from whole-genome sequencing predicts platinum response in triple-negative breast cancers
8. Intratumoral microbiome is driven by metastatic site and associated with immune histopathological parameters: An ancillary study of the SHIVA clinical trial
9. PI 3-Kinase and the Histone Methyl-Transferase KMT2D Collaborate to Induce Arp2/3-Dependent Migration of Mammary Epithelial Cells
10. Switch to fulvestrant and palbociclib versus no switch in advanced breast cancer with rising ESR1 mutation during aromatase inhibitor and palbociclib therapy (PADA-1): a randomised, open-label, multicentre, phase 3 trial
11. VEGF and VEGFR family members are expressed by neoplastic cells of NF1-associated tumors and may play an oncogenic role in malignant peripheral nerve sheath tumor growth through an autocrine loop
12. Molecular profiling of non-small-cell lung cancer patients with or without brain metastases included in the randomized SAFIR02-LUNG trial and association with intracranial outcome
13. Cytidine deaminase activity increases in the blood of breast cancer patients
14. Author Correction: Cytidine deaminase activity increases in the blood of breast cancer patients
15. Genome-wide methylation analyses identifies Non-coding RNA genes dysregulated in breast tumours that metastasise to the brain
16. Pan‐cancer evaluation of tumor‐infiltrating lymphocytes and programmed cell death protein ligand‐1 in metastatic biopsies and matched primary tumors.
17. Cellular origin and clonal evolution of human dedifferentiated liposarcoma.
18. Evaluation of Combined Chemotherapy and Genomic-Driven Targeted Therapy in Patient-Derived Xenografts Identifies New Therapeutic Approaches in Squamous Non-Small-Cell Lung Cancer Patients.
19. Correction to: Human papilloma virus (HPV) integration signature in Cervical Cancer: identification of MACROD2 gene as HPV hot spot integration site
20. The prognosis of patients treated with everolimus for advanced ER‐positive, HER2‐negative breast cancer is driven by molecular features
21. PI 3-Kinase and the Histone Methyl-Transferase KMT2D Collaborate to Induce Arp2/3-Dependent Migration of Mammary Epithelial Cells
22. Metastasis-suppressor NME1 controls the invasive switch of breast cancer by regulating MT1-MMP surface clearance
23. Pharmacologic Normalization of Pancreatic Cancer-Associated Fibroblast Secretome Impairs Prometastatic Cross-Talk With Macrophages
24. Interleukin-8 Receptors CXCR1 and CXCR2 Are Not Expressed by Endothelial Colony-forming Cells
25. Human papilloma virus (HPV) integration signature in Cervical Cancer: identification of MACROD2 gene as HPV hot spot integration site
26. Familial uveal melanoma and other tumours in 25 families with monoallelic germline MBD4 variants
27. Inactivating negative regulators of cortical branched actin enhances persistence of single cell migration
28. HRAS is a therapeutic target in malignant chemo-resistant adenomyoepithelioma of the breast
29. Circulating tumor DNA as a dynamic biomarker of response to palbociclib and fulvestrant in metastatic breast cancer patients
30. Molecular features of untreated breast cancer and initial metastatic event inform clinical decision-making and predict outcome: long-term results of ESOPE, a single-arm prospective multicenter study
31. Analysis of genomic and non-genomic signaling of estrogen receptor in PDX models of breast cancer treated with a combination of the PI3K inhibitor alpelisib (BYL719) and fulvestrant
32. The mitochondrially-localized nucleoside diphosphate kinase D (NME4) is a novel metastasis suppressor
33. Valproic Acid Decreases Endothelial Colony Forming Cells Differentiation and Induces Endothelial-to-Mesenchymal Transition-like Process
34. A single droplet digital PCR for ESR1 activating mutations detection in plasma
35. Familial uveal melanoma and other tumors in 25 families with monoallelic germline MBD4 variants.
36. Pathogenic alterations in PIK3CA and KMT2C are frequent and independent prognostic factors in anal squamous cell carcinoma treated with salvage abdominoperineal resection
37. NF1 alterations in cancers: therapeutic implications in precision medicine
38. Molecular characterisation of tumours of the lacrimal apparatus
39. #438 Molecular alterations predictive of outcome in early staged cervical cancer : a translational investigation from the SENTICOL III trial
40. Involvement of Aryl hydrocarbon receptor in myelination and in human nerve sheath tumorigenesis
41. Human Aortic Valve Interstitial Cells Display Proangiogenic Properties During Calcific Aortic Valve Disease
42. Medullary Breast Carcinoma, a Triple-Negative Breast Cancer Associated with BCLG Overexpression
43. Comprehensive clinical and molecular analyses of neuroendocrine carcinomas of the breast
44. Relevance of a molecular tumour board (MTB) for patients’ enrolment in clinical trials: experience of the Institut Curie
45. Cortical branched actin determines cell cycle progression
46. Interleukin-8 release by endothelial colony-forming cells isolated from idiopathic pulmonary fibrosis patients might contribute to their pathogenicity
47. Endothelial Colony-Forming Cells Do Not Participate to Fibrogenesis in a Bleomycin-Induced Pulmonary Fibrosis Model in Nude Mice
48. Coronin 1C promotes triple-negative breast cancer invasiveness through regulation of MT1-MMP traffic and invadopodia function
49. PLK1 inhibition exhibits strong anti-tumoral activity in CCND1-driven breast cancer metastases with acquired palbociclib resistance
50. Male breast cancer: No evidence for mosaic BRCA1 promoter methylation involvement
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.